Introduction {#s1}
============

Accurate duplication of a cell's genetic information is essential to maintain genome stability. Proper regulation of DNA replication is necessary to prevent mutations and other chromosome aberrations that are associated with cancer and developmental abnormalities ([@bib41]). DNA replication begins at thousands of cis-acting sites termed origins of replication. The Origin Recognition Complex (ORC) binds to replication origins where, together with Cdt1 and Cdc6, it loads an inactive form of the MCM2-7 replicative helicase ([@bib11]). Inactive helicases are phosphorylated by two key kinases, S-CDK and Dbf4-dependent kinase (DDK), which results in the activation of the helicase and recruitment of additional factors to form a pair of bi-directional replication forks emanating outward from the origin of replication ([@bib72]). Although many layers of regulation control the initiation of DNA replication, much less is known about how replication fork progression is regulated.

In metazoans, replication origins are not sequence specific and are likely specified by a combination of epigenetic and structural features ([@bib2]; [@bib15]; [@bib26]; [@bib51]; [@bib52]; [@bib63]). Furthermore, replication origins are not uniformly distributed throughout the genome. The result of non-uniform origin distribution is that, in origin-poor regions of the genome, a single replication fork must travel great distances to complete replication. If a replication fork encounters an impediment within a large origin-less region of the genome, then replication will be incomplete, resulting in genome instability ([@bib54]). In fact, origin-poor regions of the genome are known to be associated with chromosome fragility and genome instability ([@bib21]; [@bib25]; [@bib44]; [@bib58]). This highlights the need to regulate both the initiation and elongation phases of DNA replication to maintain genome stability.

DNA replication is also regulated in a temporal manner where specific DNA sequences replicate at precise times during S phase, a process known as the DNA replication timing program. While euchromatin replicates in the early part of S phase, heterochromatin and other repressive chromatin types replicate in the latter portion of S phase ([@bib30]; [@bib64]). Although the process of replication timing has been appreciated for many years, the underlying molecular mechanisms controlling timing have remained elusive. The discovery of factors that regulate the DNA replication timing program, however, demonstrate that replication timing is an actively regulated process.

One factor that regulates replication timing from yeast to humans is Rif1 (Rap1-interacting factor 1). Rif1 was initially identified as a regulator of telomere length in budding yeast ([@bib35]), but this function of Rif1 appears to be specific to yeast ([@bib81]). Subsequently, Rif1 has been shown to regulate multiple aspects of DNA replication and repair. In mammalian cells, Rif1 has been shown to regulate DNA repair pathway choice by preventing resection of double-strand breaks and favoring non-homologous end joining (NHEJ) over homologous recombination ([@bib16]; [@bib23]; [@bib85]). Rif1 from multiple organisms contains a Protein Phosphatase 1 (PP1) interaction motif and Rif1 is able to recruit PP1 to DDK-activated helicases to inactive them and prevent initiation of replication ([@bib20]; [@bib37]; [@bib38]).

In yeasts, flies and mammalian cells, Rif1 has been shown to regulate the replication timing program ([@bib19]; [@bib36]; [@bib59]; [@bib77]; [@bib82]). The precise mechanism(s) through which Rif1 functions to control replication timing are not fully understood. For example, Rif1 has been show to interact with Lamin and is thought to tether specific regions of the genome to the nuclear periphery ([@bib29]). How this activity is related to Rif1's ability to inactivate helicases together with PP1 in controlling the timing program remains obscure.

Studying DNA replication in the context of development provides a powerful method to understand how DNA replication is regulated both spatially and temporally. Although DNA replication is a highly ordered process, it must be flexible enough to accommodate the changes in S phase length and cell cycle parameters that occur as cells differentiate ([@bib49]). For example, during *Drosophila* development the length of S phase can vary from \~8 hr in a differentiated mitotic cell to 3 -- 4 min during early embryonic cell cycles ([@bib13]; [@bib75]). Additionally, many tissues and cell types in *Drosophila* are polyploid, having multiple copies of the genome in a single cell ([@bib27]; [@bib46]; [@bib84]).

In polyploid cells, copy number is not always uniform throughout the genome ([@bib66]; [@bib40]; [@bib75]). Both heterochromatin and several euchromatic regions of the genome have reduced DNA copy number relative to overall ploidy ([@bib55]). Underreplicated euchromatic regions of the genome share key features with common fragile sites in that they are devoid of replication origins, late replicating, display DNA damage and are tissue-specific ([@bib6]; [@bib56]; [@bib71]; [@bib83]). The presence of underreplication is conserved in mammalian cells, but the mechanism(s) mammalian cells use to promote underreplication is unknown ([@bib33]). In *Drosophila*, underreplication is an active process that is largely dependent on the distribution of ORC and on the Suppressor of Underreplication protein, SUUR ([@bib39]; [@bib48]; [@bib57]).

Understanding how the SUUR protein functions will significantly increase our understanding of the developmental control of DNA replication. The SUUR protein has a recognizable SNF2-like chromatin remodeling domain at its N-terminus, but based on sequence analysis, this domain is predicted to be defective for ATP binding and hydrolysis ([@bib48]; [@bib57]). Outside of the SNF2 domain, SUUR has no recognizable motifs or domains, which has hampered a mechanistic understanding of how SUUR promotes underreplication. Recently, however, SUUR was shown to control copy number by directly reducing replication fork progression ([@bib56]). SUUR associates with active replication forks and while loss of SUUR function results in increased replication fork progression, overexpression of SUUR drastically inhibits fork progression without affecting origin firing ([@bib56]; [@bib71]). These findings, together with previous work showing that loss of SUUR function has no influence on ORC binding ([@bib71]) and that SUUR associates with euchromatin in an S phase-dependent manner ([@bib43]), further supports SUUR as a direct inhibitor of replication fork progression within specific regions of the genome. The mechanism through which SUUR is recruited to replication forks and how it inhibits their progression remains poorly understood.

Here we investigate how SUUR is recruited to replication forks and how it inhibits fork progression. We show that localization of SUUR to replication forks, but not heterochromatin, is dependent on its SNF2 domain. We identify an interaction between SUUR and the conserved replication factor Rif1, indicating they are in the same protein complex. Importantly, we demonstrate that underreplication is dependent on *Rif1*. Critically, we have shown that Rif1 localizes to replication forks in an SUUR-dependent manner, where it acts downstream of SUUR to control replication fork progression. Our findings provide mechanistic insight into the process of underreplication and define a new function for Rif1 in replication control.

Results {#s2}
=======

The SNF2 domain is essential for SUUR function and replication fork localization {#s2-1}
--------------------------------------------------------------------------------

As a first step in understanding the mechanism of SUUR function, we wanted to define how it is localized to replication forks. SUUR has only one conserved domain: a SNF2-like domain in its N-terminal region that is predicted to be defective for ATP binding and hydrolysis ([@bib48]; [@bib57]). To study the function of SUUR's SNF2 domain, we generated a mutant in which the SNF2 domain was deleted and the resulting mutant protein was expressed under the control of the endogenous *SuUR* promoter. This mutant, *SuUR^∆SNF^,* was then crossed to an *SuUR* null mutant so that it was the only form of the the SUUR protein present ([Figure 1A](#fig1){ref-type="fig"}). We tested the function of the SUUR^∆SNF^ mutant protein by assessing its ability to promote underreplication in the larval salivary gland. We purified genomic DNA from larval salivary glands isolated from wandering third instar larvae and generated genome-wide copy number profiles using Illumina-based sequencing. We compared the results we obtained from the *SuUR^∆SNF^* mutant to copy number profiles from wild-type (WT) and *SuUR* null mutant salivary glands. To identify underreplicated domains, we used CNVnator, which identifies copy number variants (CNVs) based on a statistical analysis of read depth ([@bib1]). To be called as underreplicated, regions must not be called as underreplicated in 0 -- 2 hr embryo samples that have uniform copy number and must be larger than 10 kb.

![The SNF2 domain is essential for SUUR function and replication fork localization.\
(**A**) Schematic representation of the SUUR and SUUR^ΔSNF^ proteins. (**B**) Illumina-based copy number profiles (Reads Per Million; RPM) of *chr2L* 1 -- 20,000,000 from larval salivary glands. Black bars below each profile represent underreplicated regions identified by CNVnator. (**C**) Average read depth in regions of euchromatic underreplication domains called in wild-type salivary glands vs. the fully replicated regions of the genome. A Welch Two Sample t-test was used to determine p values. (**D**) Quantitative droplet-digital PCR (ddPCR) copy number assay for multiple underreplicated regions. Each bar is the average enrichment relative to a fully replicated control region for three biological replicates. Error bars are the SEM. (**E**) Localization of SUUR in wild-type and *SuUR^ΔSNF^* mutant follicle cells. A single representative stage 13 follicle cell nucleus is shown. Arrowheads indicate sites of amplification. Asterisk marks the chromocenter (heterochromatin). Scale bars are 2 μm. DAPI = blue, SUUR = green, EdU = red. The following source data, figure supplements and supplementary files are available for [Figure 1](#fig1){ref-type="fig"}: [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}; [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}; [Supplementary file 1](#supp1){ref-type="supplementary-material"} - Underreplicated regions called by CNVnator; [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"} -- Raw data for 1D; [Figure 1---figure supplements 2---source data 1](#fig1s2sdata1){ref-type="supplementary-material"} image intensity data.\
10.7554/eLife.39140.006Figure 1---source data 1.ddPCR data for [Figure 1D](#fig1){ref-type="fig"}.](elife-39140-fig1){#fig1}

The effect of deleting the SNF2 domain was qualitatively and quantitatively similar to the *SuUR* null mutant. Qualitatively, underreplication was suppressed in the *SuUR^∆SNF^* mutant and the copy number profile was similar to the *SuUR* null mutant ([Figure 1B](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Quantitatively, out of the 90 underreplicated sites identified in WT salivary glands, 59 were not detected in the *SuUR^∆SNF^* mutant ([Supplementary file 1](#supp1){ref-type="supplementary-material"}) and copy number was significantly increased in the euchromatic underreplicated domains similar to the *SuUR* null mutant ([Figure 1C](#fig1){ref-type="fig"}). We validated our deep-sequencing findings using quantitative droplet digital PCR (ddPCR) at four underreplicated domains ([Figure 1D](#fig1){ref-type="fig"}). Our findings show that the SNF2-like domain of SUUR is necessary to promote underreplication.

To determine if the SUUR^∆SNF^ protein was still able to associate with chromatin, we localized SUUR and the SUUR^∆SNF^ mutant proteins in ovarian follicle cells. During follicle cell development, these cells undergo programmed changes in their cell cycle and DNA replication programs ([@bib18]; [@bib40]). At a precise time in their differentiation program, follicle cells cease genomic replication and amplify six defined sites of their genome through a re-replication-based mechanism. Early in this gene amplification process, both initiation and elongation phases of replication are coupled. Later in the process, however, initiation no longer occurs and active replication forks can be visualized by pulsing amplifying follicle cells with 5-ethynyl-2'-deoxyuridine (EdU) ([@bib17]). Active replication forks resolve into a double-bar structure, where each bar represents a series of active replication forks travelling away from the origin of replication ([@bib18]). By monitoring SUUR localization in amplifying follicle cells, we can unambiguously determine if SUUR associates with active replication forks.

SUUR has two distinct modes of chromatin association during the endo cycle. It constitutively localizes to heterochromatin and dynamically associates with replication forks ([@bib43]; [@bib56]; [@bib79]). In agreement with previous studies, SUUR localized to both replication forks and heterochromatin in amplifying follicle cells ([Figure 1E](#fig1){ref-type="fig"}) ([@bib56]). In contrast, the SUUR^∆SNF^ mutant localized to heterochromatin, but its recruitment to active replication forks was severely reduced ([Figure 1E](#fig1){ref-type="fig"}; [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Together, these results demonstrate that the SNF2 domain is important for SUUR recruitment to replication forks and is essential for SUUR-mediated underreplication.

SUUR associates with Rif1 {#s2-2}
-------------------------

Interestingly, overexpression of the SNF2 domain and C-terminal portion of SUUR have different underreplication phenotypes. Whereas overexpression of the C-terminal two-thirds of SUUR promotes underreplication ([@bib42]), overexpression of the SNF2 domain suppresses underreplication in the presence of endogenous SUUR ([@bib42]). The C-terminal region of SUUR, however, has no detectable homology or conserved domains ([@bib48]). These observations, together with our own results demonstrating that the SNF2 domain of SUUR is responsible for its localization to replication forks, led us to hypothesize that SUUR is recruited to replication forks through its SNF2 domain where it could recruit an additional factor(s) through its C-terminus to inhibit replication fork progression.

To test the hypothesis that a critical factor interacts with the C-terminal region of SUUR to promote underreplication, we used immunoprecipitation mass spectrometry studies to identify SUUR-interacting proteins. We generated flies that expressed FLAG-tagged full-length SUUR or the SNF2 domain of SUUR under control of the *hsp70* promoter, induced and immunoprecipitated these constructs and identified associated proteins through mass spectrometry. We verified that both full-length SUUR and the SNF2 domain were expressed equally ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). If SUUR recruits a factor to replication forks outside of its SNF2 domain, then we would expect this factor to be present only in full-length purifications and not in the SNF2 domain purification. A single protein fulfilled this criteria: Rif1 ([Figure 2A](#fig2){ref-type="fig"}). This result raises the possibility Rif1 works together with SUUR to inhibit replication fork progression.

![SUUR associates with Rif1.\
(**A**) Total spectrum counts of FLAG-SUUR, FLAG-SNF2 and Oregon R (no FLAG control) for three independent IP-mass spectrometry experiments (biological replicates). A Fisher's Exact test of spectrum counts was used to determine significance. (**B**) Immunoprecipitation of FLAG-SUUR and no FLAG control (wild-type) from 0 to 24 hr embryos extracted with NP40 lysis buffer with or without Benzonase treatment. Membranes were probed with anti-Rif1 and anti-FLAG antibodies to monitor Rif1 and SUUR, respectively. The following source data and figure supplement are available for [Figure 2](#fig2){ref-type="fig"}: [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}; [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}; [Figure 2---source data 1](#fig2sdata1){ref-type="supplementary-material"} -- SUUR mass spectrometry total spectrum counts; [Figure 2---figure supplements 2---source data 1](#fig2s2sdata1){ref-type="supplementary-material"} -- embryo hatch rata data.\
10.7554/eLife.39140.011Figure 2---source data 1.Results of SUUR IP-mass spec screen.](elife-39140-fig2){#fig2}

To ensure that the association between SUUR and Rif1 was not bridged by chromatin, we used NP40 to extract chromatin proteins and treated the extract with Benzonase to digest DNA. We then immunoprecipitated FLAG-SUUR and used Western blotting to determine if Rif1 could co-IP using a highly specific anti-Rif1 antibody ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Even in these conditions, SUUR was able to co-IP Rif1 ([Figure 2B](#fig2){ref-type="fig"}; [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). We conclude that SUUR and Rif1 exist in the same protein complex and the interaction between SUUR and Rif1 is independent of chromatin bridging.

Underreplication is dependent on Rif1 {#s2-3}
-------------------------------------

If SUUR recruits Rif1 to replication forks to promote underreplication, then underreplication should be dependent on *Rif1*. To test this hypothesis, we used CRISPR-based mutagenesis to generate *Rif1* null mutants in *Drosophila* ([@bib9]; [@bib31]) ([Figure 3A](#fig3){ref-type="fig"}). Western blot analysis of ovary extracts from two deletion mutants, *Rif1^1^* and *Rif1^2^,* show no detectable Rif1 protein ([Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}). Also, no signal was detected in the *Rif1^1^/Rif1^2^* mutant by immunofluorescence ([Figure 2---figure supplement 2B](#fig2s2){ref-type="fig"}). The *Rif1^1^/Rif1^2^* null mutant was viable and fertile showing only a modest defect in embryonic hatch rate relative to wild-type flies with a 92% hatch rate for wild-type embryos vs. 88% for the *Rif1^1^/Rif^2^* mutant embryos ([Figure 2---figure supplement 2C](#fig2s2){ref-type="fig"}). This is in contrast to a previous study reporting *Rif1* is essential in *Drosophila* ([@bib77]) and consistent with a recent study that generated an independent *Rif1* null mutant using CRISPR-based mutagenesis ([@bib68]). Rif1's essentiality, however, was based on RNAi and not a mutation of the *Rif1* gene ([@bib77]). The most likely explanation for this discrepancy is that the lethality in the RNAi experiments was due to an off-target effect.

![Rif1 is required for underreplication.\
(**A**) Schematic representation of the *Rif1* gene and CRISPR-induced *Rif1* mutants. Lightning bolts represent the 5' and 3' gRNA positions. (**B**) Illumina-based copy number profiles of the *chr2L* from larval salivary glands. Black bars below each profile represent underreplicated regions identified by CNVnator. The wild-type and *SuUR* profiles are the same as in [Figure 1b](#fig1){ref-type="fig"}. (**C**) Average read depth in regions of euchromatic underreplication domains called in wild-type salivary glands vs. the fully replicated regions of the genome. A Welch Two Sample t-test was used to determine p values. (**D**) Quantitative droplet-digital PCR (ddPCR) copy number assay for multiple underreplicated regions. Each bar is the average enrichment relative to a fully replicated control region for three biological replicates. Error bars are the SEM. The following source data and figure supplement are available for [Figure 3](#fig3){ref-type="fig"}: [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}; [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}; [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}; [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}; [Figure 3---figure supplement 2---source data 1](#fig3s2sdata1){ref-type="supplementary-material"} - Raw data for 2B.\
10.7554/eLife.39140.017Figure 3---source data 1.ddPCR data for [Figure 3D](#fig3){ref-type="fig"}.](elife-39140-fig3){#fig3}

To determine if *Rif1* is necessary for underreplication, we dissected salivary glands from *Rif1^1^*/*Rif1^2^* (herein referred to as *Rif1^-^*) heterozygous larvae and extracted genomic DNA for Illumina-based sequencing to measure changes in DNA copy number. Strikingly, underreplication is abolished upon loss of Rif1 function ([Figure 3B and C](#fig3){ref-type="fig"}; [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). We validated our sequence-based copy number assays with quantitative PCR at a subset of underreplicated regions using ddPCR ([Figure 3D](#fig3){ref-type="fig"}). Furthermore, we determined the read density at all euchromatic sites of underreplication called in our wild-type samples, which quantitatively demonstrates that Rif1 is essential for underreplication ([Figure 3C](#fig3){ref-type="fig"}). These results demonstrate that underreplication is dependent on *Rif1*.

It is possible that the *Rif1* mutant indirectly influences underreplication through changes in replication timing. Underreplicated domains, both euchromatic and heterochromatic, tend to be late replicating regions of the genome ([@bib12]; [@bib48]). Therefore, if these regions replicated earlier in S phase in a *Rif1* mutant, then this change could prevent their underreplication. In fact, SUUR associates with late replicating regions of the genome ([@bib28]; [@bib60]). Due to their large polyploid nature, salivary gland cells cannot be sorted to perform genome-wide replication timing experiments. Because heterochromatin replicates exclusively in late S phase, however, late replication can be visualized when EdU is incorporated exclusively in regions of heterochromatin. To assess if *Rif1* mutants have a clear pattern of late replication in larval salivary glands, we isolated salivary glands from early 3rd instar larvae, which are actively undergoing endo cycles. We pulsed these salivary glands with EdU to visualize sites of replication and co-stained with an anti-HP1 antibody to mark heterochromatin. In wild-type salivary glands, only rarely (1 of 238 EdU^+^ cells; 0.4%) did we detect EdU incorporation in regions of heterochromatin ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). This is consistent with the lack of heterochromatin replication due to underreplication. In contrast, in both *SuUR* and *Rif1* mutants, we could readily detect cells that were solely incorporating EdU within regions of heterochromatin (32 of 327 EdU^+^ cells; 9.8% for *SuUR* and 70 of 385 EdU^+^ cells; 18.2% for *Rif1*) ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). Therefore, we conclude that *Rif1* mutants still have a clear pattern of late replication. Given that heterochromatin underreplication is suppressed in a *Rif1* mutant, although it is still late replicating, indicates that replication timing cannot solely explain the lack of underreplication associated with loss of Rif1 function.

While characterizing Rif1's role in underreplication and patterns of DNA replication in endo cycling cells, we did observe differences in the heterochromatic regions of *SuUR* and *Rif1* mutants. First, although underreplication is suppressed in both mutants ([Figure 3](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), the chromocenters were abnormally large in the *Rif1* mutant relative to an *SuUR* mutant as observed by DAPI staining consistent with the 'fluffy' enlarged chromocenters seen in Rif1 mutant mouse cells ([Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}) ([@bib19]). Although, this phenotype was present in all endo cycling cells, it was especially dramatic in the ovarian nurse cells ([Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}). Second, Illumina-based copy number profiles revealed an increase in copy number in some pericentric heterochromatin regions in the *Rif1* mutant relative to the *SuUR* mutant ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Collectively, these results suggest that heterochromatin is partially, but not fully replicated in *SuUR* mutant endo cycling cells, consistent with previous cytological analysis ([@bib22]). In contrast, loss of Rif1 function appears to completely restore heterochromatic replication in endo cycling cells.

Rif1 affects replication fork progression {#s2-4}
-----------------------------------------

SUUR-mediated underreplication occurs through inhibition of replication fork progression ([@bib56]; [@bib71]). If SUUR acts together with Rif1 to promote underreplication, then Rif1 is expected to control replication fork progression. DNA combing assays in human and mouse cells from multiple groups have come to different conclusions as to whether Rif1 affects replication fork progression ([@bib5]; [@bib19]; [@bib38]; [@bib82]). Rif1, however, has been shown to be associated with replication forks through nascent chromatin capture, an iPOND-like technique used to isolate proteins associated with active replication forks ([@bib3]). To determine directly if Rif1 controls replication fork progression, we performed copy number assays on amplifying follicle cells.

Gene amplification in ovarian follicle cells occurs at six discrete sites in the genome through a re-replication based mechanism. Copy number profiling of these amplified domains provides a quantitative assessment of the number of rounds of origin firing and the distance replication forks have travelled during the amplification process, allowing us to disentangle the initiation and elongation phases of DNA replication. To determine if Rif1 affects origin firing and/or replication fork progression, we isolated wild-type and *Rif1* mutant stage 13 egg chambers, which represent the end point of the amplification process, and made quantitative DNA copy number measurements. Loss of Rif1 function resulted in an increase in replication fork progression without significantly affecting copy number at the origin of replication at all sites of amplification ([Figure 4A](#fig4){ref-type="fig"}). The increase in fork progression observed in the *Rif1* mutant was not due to a lengthening of the developmental time window for gene amplification, as there was no significant difference in egg chamber distribution between wild-type and *Rif1* mutant ovaries ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).

![Rif1 regulates replication fork progression.\
(**A**) Illumina-based copy number profile of sites of follicle cell gene amplification. DNA was extracted from wild type and *Rif1* mutant stage 13 egg chambers and compared to DNA extracted from 0 to 2 hr embryos. The resulting graphs are the log~2~-transformed ratios of egg chamber relative to embryonic DNA. Bars below the graphs represent the distance between the half-maximum copy number on each side of the replication origin. (**B**) Fraction of cells that display visible amplification foci in each stage of gene amplification. Average of two biological replicates in which two egg chambers from each stage were used per biological replicate. 100 -- 300 follicle cells were counted per genotype. Error bars are the SEM. The following source data, supplementary file and figure supplement are available for [Figure 4](#fig4){ref-type="fig"}: [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}; [Supplementary file 2](#supp2){ref-type="supplementary-material"} -- Table of half-max values for all amplicons; [Figure 4---source data 1](#fig4sdata1){ref-type="supplementary-material"} -- raw data for 4B; [Figure 4---figure supplements 1---source data 1](#fig4s1sdata1){ref-type="supplementary-material"}-combined data for egg chamber distribution of five biological replicates.\
10.7554/eLife.39140.021Figure 4---source data 1.Data for [Figure 4B](#fig4){ref-type="fig"}.](elife-39140-fig4){#fig4}

To quantify the changes in fork progression we observed at sites of amplification, we computationally determined the peak of amplification and the region on each arm of the amplified domain that represents one half of the copy number at the highest point of the amplicon ([@bib56]). This quantitative analysis of origin firing and replication fork progression revealed that origin firing was not affected in the *Rif1* mutant, as no major change in copy number was detected at the origin of replication when comparing wild type and *Rif1* mutant stage 13 follicle cells ([Supplementary file 2](#supp2){ref-type="supplementary-material"}). In contrast, the width of each replication gradient, which represents the rate of fork progression, was significantly increased at all sites of amplification ([Figure 4A](#fig4){ref-type="fig"}; [Supplementary file 2](#supp2){ref-type="supplementary-material"}). Based on the observation that the *Rif1* mutant does not affect origin firing, but specifically affects the distance replication forks travel during the gene amplification process, and there was no change in the developmental window of gene amplification in the *Rif1* mutant, we conclude that Rif1 regulates replication fork progression.

Given that the *Rif1* mutant phenocopies an *SuUR* mutant with respect to replication fork progression, we next wanted to determine the cause of increased replication fork progression at amplified loci upon loss of Rif1 function. Previously, it was shown that a prolonged period of EdU incorporation in the *SuUR* mutant, within the 7.5 hr span of gene amplification, gives rise to the extended replication gradient at sites of amplification ([@bib56]). Gene amplification starts synchronously in all follicle cells at stage 10B of egg chamber development ([@bib14]). By the end of gene amplification, however, only a subset of follicle cells display visual amplification foci as judged by EdU incorporation, likely representing a stochastic end to the gene amplification process ([@bib56]). To determine if Rif1 controls replication fork progression by increasing the period of EdU incorporation within the 7.5 hr time window of gene amplification, comparable to an *SuUR* mutant, we quantified the fraction of stage 13 follicle cells that were EdU positive. Similar to an *SuUR* mutant, loss of Rif1 function also resulted in a prolonged period of EdU incorporation with 34% of follicle cells visibly incorporating EdU in wild-type follicle cells, 100% in an *SuUR* mutant and 98.5% in the *Rif1* mutant ([Figure 4B](#fig4){ref-type="fig"}). This result suggests that Rif1 has a destabilizing effect on replication forks, resulting in a premature cessation of replication fork progression.

Rif1 acts downstream of SUUR {#s2-5}
----------------------------

Rif1 could control SUUR activity and underreplication by at least two different mechanisms. Rif1 could act upstream of SUUR and directly or indirectly regulate SUUR's ability to associate with chromatin. For example, Histone H1 and HP1 affect underreplication by influencing SUUR's ability to associate with chromatin ([@bib7]; [@bib61]). Alternatively, Rif1 could act downstream of SUUR to control replication fork progression. We sought to distinguish between these possibilities by determining whether SUUR could still associate with replication forks in the absence of Rif1 function.

To monitor SUUR's association with heterochromatin and replication forks in the same cell type, we localized SUUR in amplifying follicle cells where replication forks (double bars) and heterochromatin (chromocenter) can be visualized unambiguously, in the presence and absence of Rif1. SUUR localized to both replication forks and heterochromatin in the absence of Rif1 function ([Figure 5](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Therefore, we conclude that Rif1 acts downstream of SUUR to inhibit fork progression and that SUUR lacks the ability to inhibit replication fork progression in the absence of Rif1.

![Rif1 acts downstream of SUUR.\
Localization of replication forks (EdU) and SUUR in a wild-type and *Rif1* mutant follicle cell nuclei. A single representative stage 13 follicle cell nucleus is shown. Scale bars are 2 μm. Arrowheads indicate sites of amplification. Asterisks marks the chromocenter (heterochromatin). DAPI = blue, SUUR = green, EdU = red. The following source data and figure supplement are available for [Figure 5](#fig5){ref-type="fig"}: [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}; [Figure 5---figure supplements 1---source data 1](#fig5s1sdata1){ref-type="supplementary-material"}--intensity data.](elife-39140-fig5){#fig5}

Rif1 localizes to active replication forks {#s2-6}
------------------------------------------

Although our genetic data indicate that Rif1 affects replication fork progression, we wanted to determine if Rif1 controls replication fork progression through a direct or indirect mechanism. If Rif1 directly influences replication fork progression and/or stability, then it should localize to active replication forks. To assess this possibility, we visualized Rif1 localization during gene amplification in follicle cells using a Rif1-specific antibody ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}).

Rif1 localization pattern was strikingly similar to that of SUUR. First, Rif1 is localized to heterochromatin in all stages of amplifying follicle cells ([Figure 6](#fig6){ref-type="fig"}). Second, Rif1 localized to sites of amplification even prior to the formation of double bar structures ([Figure 6](#fig6){ref-type="fig"}; [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Third, in the later stages of gene amplification Rif1 was localized to active replication forks. Taken together, these results demonstrate that Rif1 dynamically associates with replication forks to regulate their progression.

![SUUR is necessary to retain Rif1 at replication forks.\
Localization of active replication forks (EdU) and Rif1 in a wild-type and *SuUR* mutant follicle cell nuclei. Single representative follicle cell nuclei are shown for each stage. Scale bars are 2 μm. Arrowheads indicate sites of amplification. Asterisk marks the chromocenter (heterochromatin). The following source data and figure supplement are available for [Figure 6](#fig6){ref-type="fig"}: [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}; [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}; [Figure 6---figure supplements 1---source data 1](#fig6s1sdata1){ref-type="supplementary-material"}--intensity data; [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"} -- raw data for 2B.](elife-39140-fig6){#fig6}

To verify that Rif1 associates with replication forks in a context other than the gene amplification, we used iPOND to determine if Rif1 is associated with replication forks in cultured *Drosophila* S2 cells. Briefly, cells were pulsed with EdU and immediately fixed in formaldehyde or chased with thymidine prior to fixation. Proteins associated with newly synthesized DNA (replication forks) can be identified based on their enrichment in pulse samples relative to chase samples ([@bib24]; [@bib73]). We used mass spectrometry to quantify Rif1 protein abundance in EdU pulse and chase samples ([@bib74]). Consistent with Rif1 association with replication forks in amplifying follicle cells, Rif1 was enriched in EdU pulse samples relative to chase samples in cultured cells ([Figure 6---figure supplement 2A](#fig6s2){ref-type="fig"}). Although this enrichment was not as abundant as our PCNA-positive control, this is expected for a protein that associates with a subset of replication forks.

To independently verify that Rif1 is localized to replication forks in cultured cells, we performed a proximity ligation assay (PLA)-based approach with nascent DNA ([@bib65]; [@bib80]). *Drosophila* S2 cells were pulsed with EdU, fixed and EdU was subsequently biotinylated. A PLA assay was then performed using two different anti-biotin antibodies as a positive control, or an anti-biotin antibody together with an anti-Rif1 antibody. As a negative control, the same PLA assays were performed using cells that were not pulsed with EdU. Consistent with our iPOND mass-spec results, PLA foci were generated using anti-Rif1 and anti-biotin antibodies only when cells were pulsed with EdU ([Figure 6---figure supplement 2B](#fig6s2){ref-type="fig"}). Together, these results indicate that Rif1 is associated with replication forks in amplifying follicle cells and cultured cells.

SUUR is required to retain Rif1 at replication forks {#s2-7}
----------------------------------------------------

Based on our observations that SUUR and Rif1 are part of the same protein complex, and that a *Rif1* mutant phenocopies an *SuUR* mutant, we hypothesized that SUUR recruits a Rif1/PP1 complex to replication forks. If true, then Rif1 association with replication forks should be at least partially dependent on SUUR. To test this hypothesis, we monitored the localization of Rif1 in *SuUR* mutant amplifying follicle cells. We found that Rif1's association with replication forks was largely dependent on SUUR, as the Rif1 signal was lost in late stage amplifying follicle cells in an *SuUR* mutant ([Figure 6](#fig6){ref-type="fig"}; [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Rif1's recruitment to replication foci, however, was not completely dependent on SUUR. In a subset of stage 10B and 11 egg chambers, when both initiation of replication and fork progression are still coupled, we observed Rif1 localization to amplification foci in a subset of follicle cells ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Rif1 staining was lost, however, in stage 12 and 13 egg chambers. We conclude that while the initial recruitment of Rif1 to sites of amplification is not completely dependent on SUUR, SUUR is necessary to retain Rif1 at replication forks.

The PP1-interacting motif of Rif1 is necessary for underreplication {#s2-8}
-------------------------------------------------------------------

Because Rif1 is known to recruit PP1 to replication origins to regulate initiation, this led us to ask if the same interaction between Rif1 and PP1 is important for Rif1's regulation of replication fork progression. Rif1 associates with Protein Phosphatase 1 (PP1) through a conserved interaction motif, thereby recruiting PP1 to MCM complexes and inactivating them ([@bib20]; [@bib38]; [@bib37]). PP1 has also been shown to associate with Rif1 in *Drosophila* ([@bib68]; [@bib77]). Based on this model of Rif1 function, we wanted to determine if Rif1's PP1 interaction motif was necessary for Rif1-mediated underreplication. We used CRISPR-based mutagenesis to mutate the conserved SILK/RSVF PP1 interaction motif to SAAK/RASA. Western blot analysis showed that mutation of the SILK/RSVF motif did not affect protein stability ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). Mutation of this motif has been shown to disrupt the Rif1/PP1 interaction in organisms from yeast to humans ([@bib5]; [@bib20]; [@bib38]; [@bib37]; [@bib50]; [@bib77]; [@bib78]). We isolated salivary glands from wandering 3rd instar larvae *of the Rif1^PP1^* mutant and *Rif1^PP1^*/+ heterozygous animals as a wild-type control. We then extracted DNA and generated genome-wide copy number profiles by Illumina sequencing. Similar to the *Rif1* mutant, underreplication was largely abolished in the *Rif1^PP1^* mutant ([Figure 7A--C](#fig7){ref-type="fig"}; [Supplementary file 1](#supp1){ref-type="supplementary-material"}). Thus, Rif1's PP1-interaction motif is necessary to promote underreplication, suggesting that PP1 is a mediator of underreplication. It still remains possible, however, that an additional protein(s) could interact with this motif to promote underreplication.

![The Rif1 PP1 interaction motif is necessary to promote underreplication.\
(**A**) Illumina-based copy number profiles of *chr2L 1 - 20,000,000* from larval salivary glands. Black bars below each profile represent underreplicated regions identified by CNVnator. *Rif1^PP1^*/*CyO* was used as the wild-type control. (**B**) Average read depth in regions of euchromatic underreplication domains called in wild-type salivary glands vs. the fully replicated regions of the genome. A Welch two-sample t-test was used to determine p values. (**C**) Quantitative droplet-digital PCR (ddPCR) copy number assay for multiple underreplicated regions. Each bar is the average enrichment relative to a fully replicated control region for three biological replicates. Error bars are the SEM. (**D**) A new model for SUUR-mediated underreplication. In this model, SUUR serves as a scaffold to recruit a Rif1/PP1 complex to replication forks where Rif1/PP1 inhibits replication fork progression through dephosphorylation of a component of the replisome. The following source data and figure supplement are available for [Figure 7](#fig7){ref-type="fig"}: [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}; [Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}; [Figure 7---source data 1](#fig7sdata1){ref-type="supplementary-material"} -- raw data for 7C.\
10.7554/eLife.39140.033Figure 7---source data 1.ddPCR data for [Figure 7C](#fig7){ref-type="fig"}.](elife-39140-fig7){#fig7}

Discussion {#s3}
==========

The SUUR protein is responsible for promoting underreplication of heterochromatin and many euchromatin regions of the genome. Although SUUR was recently shown to promote underreplication through inhibition of replication fork progression, the underlying molecular mechanism has remained unclear. Through biochemical, genetic, genomic and cytological approaches, we have found that SUUR recruits Rif1 to replication forks and that Rif1 is responsible for underreplication. This model is supported by several independent lines of evidence. First, SUUR associates with Rif1, and SUUR and Rif1 co-localize at sites of replication. Second, underreplication is dependent on Rif1, although *Rif1* mutants have a clear pattern of late replication in endo cycling cells. Third, SUUR localizes to replication forks and heterochromatin in a *Rif1* mutant, however, it is unable to inhibit replication fork progression in the absence of Rif1. Fourth, Rif1 controls replication fork progression and phenocopies the effect loss of SUUR function has on replication fork progression. Fifth, SUUR is required for Rif1 localization to replication forks. Critically, using the gene amplification model to separate initiation and and elongation of replication, we have shown that Rif1 can affect fork progression without altering the extent of initiation. Based on these observations, we have defined a new function of Rif1 as a regulator of replication fork progression.

SNF2 domain and fork localization {#s3-1}
---------------------------------

Our work suggests that the SNF2 domain of SUUR is critical for its ability to localize to replication forks. This is based on the observation that deletion of this domain results in a protein that is unable to localize to replication forks, but still localizes to heterochromatin. SUUR has previously been shown to dynamically localize to replication forks during S phase, but constitutively binds to heterochromatin ([@bib43]; [@bib56]). SUUR associates with HP1 and this interaction occurs between the central region of SUUR and HP1 ([@bib61]). Therefore, we speculate that the interaction between SUUR and HP1 is responsible for constitutive SUUR localization to heterochromatin, while a different interaction between the SNF2 domain and a yet to be defined component of the replisome, or replication fork structure itself, recruits SUUR to active replication forks during S phase.

Uncoupling of SUUR's ability to associate with replication forks and heterochromatin also provides a new level of mechanistic understanding of underreplication. Overexpression of the C-terminal two-thirds of SUUR is capable of inducing ectopic sites of underreplication. In contrast, overexpression of the SUUR's SNF2 domain, in the presence of endogenous SUUR, suppresses SUUR-mediated underreplication ([@bib42]). Together with the data presented here, we suggest that overexpression of the SNF2 domain interferes with recruitment of full-length SUUR to replication forks, by saturating potential SUUR binding sites at the replication fork. Although the C-terminal region of SUUR is necessary to induce underreplication ([@bib42]), the C-terminal portion of SUUR remains associated with heterochromatin in the SUUR^ΔSNF^ construct, but this protein is not sufficient to induce underreplication. We suggest that at physiological levels, the affinity of SUUR for replication forks is substantially diminished in the absence of the SNF2 domain. Our work raises questions about the biological significance of SUUR binding to heterochromatin, since without the SNF2 domain SUUR is still constitutively bound to heterochromatin, yet unable to induce underreplication. Additionally, SUUR dynamically associates with heterochromatin in mitotic cells although heterochromatin is fully replicated ([@bib79]).

Rif1 controls underreplication {#s3-2}
------------------------------

While trying to uncover the molecular mechanism through which SUUR is able to inhibit replication fork progression, we have uncovered an interaction between SUUR and Rif1. Through subsequent analysis, we demonstrated that Rif1 has a direct role in copy number control and that Rif1 acts downstream of SUUR in the underreplication process. Although underreplication is largely dependent on SUUR, there are several sites that display a modest degree of underreplication in the absence of SUUR ([@bib22]; [@bib71]). In a *Rif1* mutant, however, these sites are fully replicated and there is no longer any detectable levels of underreplication within any regions of the genome. It is possible that Rif1 is capable of promoting underreplication through a mechanism independent of SUUR. Therefore, we conclude that Rif1 is a critical factor in driving underreplication.

Further emphasizing the critical role Rif1 plays in copy number control, we have shown that Rif1 acts downstream of SUUR in promoting underreplication. SUUR is still able to associate with chromatin in the absence of Rif1 but is unable to promote underreplication. Underreplicated regions of the genome, including heterochromatin, tend to be late replicating, raising the possibility that changes in replication timing in a *Rif1* mutant suppresses underreplication. *Rif1* mutant endo cycling cells of Drosophila display a cytological pattern of late replication, where heterochromatin is discretely replicated. While Rif1 controls replication timing in *Drosophila* and is necessary for the onset of late replication at the mid-blastula transition ([@bib68]), we argue that the changes in copy number associated with loss of Rif1 function are not solely due to a loss of late replication. This is supported by the clear pattern of late replication of heterochromatin in *Rif1* mutant endo cycling cells, although heterochromatin appears to be fully replicated in these cells. Previous work in mammalian polyploid cells has shown that underreplication is dependent on Rif1, which was attributed to changes in replication timing ([@bib34]). It is important to note that Rif1-dependent changes in replication timing were not measured in this system and that many genomic regions transition from early to late replication in a *Rif1* mutant ([@bib29]). Our work raises the possibility that Rif1 has a direct role in mammalian underreplication through a mechanism similar to that of Drosophila and may not simply be due to indirect changes in replication timing. Future work will be necessary to define the role of mammalian Rif1 in underreplication.

Rif1 regulates replication fork progression {#s3-3}
-------------------------------------------

Our analysis of amplification loci demonstrates that Rif1 controls replication fork progression independently of initiation control, thus demonstrating that Rif1 has a specific effect on replication fork progression. Therefore, we have uncovered a new role for Rif1 in DNA metabolism as a regulator of replication fork progression and copy number control. Rif1 has been identified as part of the replisome in human cells by nascent chromatin capture, a technique that identifies proteins associated with newly synthesized chromatin ([@bib3]). Multiple studies have assessed whether loss of Rif1 function affects replication fork progression in yeast, mouse and human cells, but have come to different conclusions ([@bib5]; [@bib19]; [@bib38]; [@bib82]). DNA fiber assays have been used to measure fork progression in these studies and nearly all have shown that *Rif1* mutants have a slight increase in replication fork progression, although not always statistically significant. There could be several reasons for these differing results; Rif1 may control replication fork progression in specific genomic regions that may be underrepresented in some assays, Rif1 function could vary among different cell types, or sample sizes may have been too small to reach significance. Our observations, taken together with these previous studies, leave open the possibility that Rif1-mediated control of replication fork progression could be an evolutionarily conserved function of Rif1. We do not suggest that Rif1 is constitutively associated with replication forks in all cell types. Rather, Rif1 could be recruited to replication forks at a specific time in S phase, or in specific developmental contexts, to modulate the progression of replication forks and provide an additional layer of regulation of the DNA replication program.

How could SUUR and Rif1 function in concert to inhibit replication fork progression? We have shown that Rif1 retention at replication forks is dependent on SUUR. Additionally, underreplication depends on Rif1's PP1-binding motif, raising the possibility that a Rif1/PP1 complex is necessary to inhibit replication fork progression. Rif1/PP1 dephosphorylates DDK-activated helicases to control replication initiation ([@bib20]; [@bib38]; [@bib37]). More recently, however, DDK-phosphorylated MCM subunits were shown to be necessary to maintain CMG association and stability of the helicase ([@bib5]). This result suggests that continued phosphorylation of the helicase is necessary for replication fork progression ([@bib5]). We propose that SUUR recruits Rif1/PP1 to replication forks where it is able to dephosphorylate MCM subunits, ultimately inhibiting replication fork progression. Although this mechanism needs to be tested biochemically, it provides a framework to address the underlying molecular mechanism responsible for controlling DNA copy number and could provide new insight into the mechanism(s) Rif1 employs to regulate replication timing.

Materials and methods {#s4}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\   Designation            Source or reference                               Identifiers      Additional\
  or resource                                                                                                         information
  ------------------------- ---------------------- ------------------------------------------------- ---------------- -------------------------------------
  Gene\                     *Suppressor of*\       NA                                                FBgn0025355      
  (*Drosophila*\            *Underreplication*\                                                                       
  *melanogaster*)           (*SuUR*)                                                                                  

  Gene\                     *Rap1 interacting*\    NA                                                FBgn0050085      
  (*D.*\                    *factor 1 (Rif1)*                                                                         
  *melanogaster*)                                                                                                     

  Strain, strain\           WT: *Oregon R*                                                                            
  background\                                                                                                         
  (*D.*\                                                                                                              
  *melanogaster*)                                                                                                     

  Strain, strain\           *SuUR*                 ([@bib48])\                                                        *w^118^; SuUR^ES^*
  background\                                      PMID: 11901119                                                     
  (*D.*\                                                                                                              
  *melanogaster*)                                                                                                     

  Strain, strain\           *SuUR^ΔSNF^*           This paper                                                         *SuUR^ES^*,\
  background\                                                                                                         *PBac*{w^+^ *SuUR^ΔSNF^}*
  (*D.*\                                                                                                              
  *melanogaster*)                                                                                                     

  Strain, strain\           *hs \> FLAG-SUUR*      This paper                                                         *w118; hs \> FLAG-SUUR*
  background\                                                                                                         
  (*D.*\                                                                                                              
  *melanogaster*)                                                                                                     

  Strain, strain\           *hs \> FLAG-SNF2*      This paper                                                         *w^118^*; *hs \> FLAG-SNF2*
  background\                                                                                                         
  (*D.*\                                                                                                              
  *melanogaster*)                                                                                                     

  Strain, strain\           *Rif1^1^*              This paper                                                         *w^118^*; *Rif1^1^*
  background\                                                                                                         
  (*D.*\                                                                                                              
  *melanogaster*)                                                                                                     

  Strain, strain\           *Rif1^2^*              This paper                                                         *w^118^*; *Rif1^2^*
  background\                                                                                                         
  (*D.*\                                                                                                              
  *melanogaster)*                                                                                                     

  Strain, strain\           *Rif1^-^*              This paper                                                         *w^118^*; *Rif1^1^*/*Rif1^2^*
  background\                                                                                                         
  (*D.*\                                                                                                              
  *melanogaster*)                                                                                                     

  Strain, strain\           *Rif1^PP1^*            This paper                                                         *w^118^*; *Rif1^PP1^*
  background\                                                                                                         
  (*D.*\                                                                                                              
  *melanogaster)*                                                                                                     

  Cell line\                S2-DGRC                Drosophila Genomics Resource Center (DGRC)        embryo derived   isolate of S2 used for RNAi in the\
  (*D.*\                                                                                                              DRSC\
  *melanogaster*)                                                                                                     modENCODE line

  Antibody                  anti-SUUR\             ([@bib55]) PMID: 25437540)                                         
                            (Guinea pig,\                                                                             
                            polyclonal)                                                                               

  Antibody                  anti-Rif1\             This paper                                                         (1:200)
                            (Guinea pig,\                                                                             
                            polyclonal)                                                                               

  Antibody                  anti-Rif1\             This paper                                                         (1:1000)
                            (Rabbit,\                                                                                 
                            polyclonal)                                                                               

  Antibody                  HRP-anti-FLAG\         Sigma-Aldrich                                     A8592            (1:1000)
                            (Mouse,\                                                                                  
                            monoclonal)                                                                               

  Antibody                  anti-HP1\              The Developmental Studies Hybridoma Bank (DSHB)   C1A9             (1:1000)
                            (Mouse,\                                                                                  
                            monoclonal)                                                                               

  Antibody                  anti-biotin (Mouse,\   Sigma-Aldrich                                     SAB4200680       (1:20,000)
                            moncolonal)                                                                               

  Antibody                  anti-biotin\           Bethyl                                            A150-109A        (1:3,000)
                            (rabbit, polyclonal)                                                                      

  Antibody                  HRP-secondaries        Jackson\                                                           (1:20,000)
                                                   ImmunoResearch                                                     

  Recombinant\              pCaSpeR-hs             (Thummel and Pirrotta,\                                            
  DNA reagent                                      V.)Drosophila Genomics Resource Center                             

  Recombinant\              pStinger               ([@bib8]) PMID: 11056799                                           
  DNA reagent                                                                                                         

  Recombinant\              CHORI-322\             BACPAC Resources                                                   
  DNA reagent               (CH322-163L18)                                                                            

  Recombinant\              pET17b                 Millipore-Sigma                                   69663            
  DNA reagent                                                                                                         

  Recombinant\              pET17b-Rif1\           This paper                                                         Progenitors:PCR, pET17b
  DNA reagent               (694--1094)                                                                               

  Peptide,\                 Rif1(694--1094)        This paper                                                         Ni-NTA purified
  recombinant\                                                                                                        
  protein                                                                                                             

  Commercial\               PLA probes             Duolink Sigma                                                      
  assay or kit                                                                                                        

  Commercial\               PLA probemaker         Duolink Sigma                                     DUO92010         
  assay or kit                                                                                                        

  Commercial\               PLA Detection\         Duolink Sigma                                     DUO92008         
  assay or kit              Reagents                                                                                  

  Chemical\                 Alexa Fluor\           Life Technologies                                 A20012           
  compound,\                Azide 555                                                                                 
  drug                                                                                                                

  Chemical\                 Biotin-TEG Azide       Berry and Associates                              BT 1085          
  compound,\                                                                                                          
  drug                                                                                                                

  Chemical\                 EdU\                   Life Technologies                                 A10044           
  compound,\                (5-ethynyl-2-\                                                                            
  drug                      deoxyuridine)                                                                             

  Software,\                Sequest                Thermo Scientific                                                  
  algorithm                                                                                                           

  Software,\                Scaffold 4.3.4         Proteome Software                                                  
  algorithm                                                                                                           

  Software,\                Skyline\               [@bib67] (PMID:22454539)                                           
  algorithm                 version 4.1                                                                               

  Software,\                deepTool 2.5.0         [@bib62] (PMID:27079975)                                           
  algorithm                                                                                                           

  Software,\                CNVnator 0.3.3         [@bib1]\                                                           
  algorithm                                        (PMID:21324876)                                                    

  Other                                                                                                               
  ---------------------------------------------------------------------------------------------------------------------------------------------------------

Strain list {#s4-1}
-----------

JTN110: WT -- Oregon R

JTN109*: SuUR^-^ -- w^118^; SuUR^ES^*

JTN038*: SuUR^ΔSNF^ -- SuUR^ES^*, *PBac*{w^+^ *SuUR^ΔSNF^}*

JTN143: *w^118^; hs \> FLAG-SUUR*

JTN146: *w^118^; hs \> FLAG-SNF2*

JTN305: w^118^; Rif1^1^

JTN307: *w^118^; Rif1^2^Rif1*^-^ -- *w^118^; Rif1^1^*/*Rif1^2^*

JTN292: *Rif1^PP1^ -- w^118^; Rif1^PP1^*

BAC-mediated recombineering {#s4-2}
---------------------------

BAC-mediated recombineering ([@bib70]) was used to delete the portion of the *SuUR* gene corresponding to the SNF2 domain. An *attB-P\[acman\]* clone with a 21 kb genomic region containing the *SuUR* and a *galK* insertion in the *SuUR* coding region (described in \[[@bib56]\]) was used as a starting vector. Next, a gene block (IDT) was used to replace the gal*K* cassette and generate a precise deletion within the *SuUR* gene. The resulting vector was verified by fingerprinting, PCR and sequencing. The *SuUR^ΔSNF^* BAC was injected into a strain harboring the *86* F8 landing site (Best Gene Inc.).

Generation of heat shock-inducible, FLAG-tagged SuUR transgenic lines {#s4-3}
---------------------------------------------------------------------

The portion of the *SuUR* gene encoding the SNF2 domain (amino acids 1 to 278) was fused to the SV40 NLS ([@bib8]) and a 3X-FLAG tag sequence was added to the 5' end of *SuUR SNF2* sequence. The resulting construct was cloned into the pCaSpeR-hs vector, which contains a *hsp70* promoter (Thummel and Pirrotta, V.: Drosophila Genomics Resource Center), using the NotI and XbaI restriction sites. A 3X-FLAG tag sequence was added to the 5' end of of the *SuUR* coding region and cloned into the pCaSpeR-hs vector also using the NotI and XbaI restriction sites. The resulting constructs were verified by sequencing and injected into a *w^1118^* strain (Best Gene Inc.).

CRISPR mutagenesis {#s4-4}
------------------

To generate null alleles of *Rif1*, gRNAs targeting the 5' and 3' ends of the *Rif1* gene were cloned into the pU6-BbsI plasmid as described ([@bib32]) using the DRSC Find CRISPRs tool (<http://www.flyrnai.org/crispr2/index.html>). Both gRNAs were co-injected into a *nos-Cas9* expression stock (Best Gene Inc.). Surviving adults were individually crossed to *CyO*/*Tft* balancer stock and *CyO*-balanced progeny were screened by PCR for a deletion of the *Rif1* locus. Stocks harboring a deletion were further characterized by sequencing. Both *Rif1^1^* and *Rif1^2^* mutants had substantial deletions of the *Rif1* gene and both had frame shift mutations early in the coding region. *Rif1^1^* has a frame shift mutation at amino acid 14, whereas *Rif1^2^* has a frame shift mutation at amino acid 11.

To generate a *Rif1* allele defective for PP1 binding, the pU6-BbsI vector expressing the gRNA targeting the 3' end of *Rif1* was co-injected with a recovery vector that contained the mutagenized SILK and RVSV (SAAK and RASA) sites with 1 kb of homology upstream and downstream of the mutagenized region. Surviving adults were crossed as above and screened by sequencing.

Cytological analysis and microscopy {#s4-5}
-----------------------------------

Ovaries were dissected from females fattened for two days on wet yeast in Ephrussi Beadle Ringers (EBR) medium ([@bib10]). Ovaries were pulsed with 5-ethynyl-2-deoxyuridine (EdU) for 30 min, fixed in 4% formaldehyde and prepared for immunofluorescence (IF) as described ([@bib56]).

For IF using both anti-Rif1 and anti-SUUR antibodies, ovaries were dissected, pulsed with 50 μM EdU and fixed. Ovaries were then incubated in primary antibody (1:200) overnight at 4°C. Alexa Fluor secondary antibodies (ThermoFisher) were used at a dilution of 1:500 for 2 hr at room temperature. EdU detection was performed after incubation of the secondary antibody using Click-iT Alexa Fluor-555 or −488 (Invitrogen). All images were obtained using a Nikon Ti-E inverted microscope with a Zyla sCMOS digital camera. Images were deconvolved and processed using NIS-Elements software (Nikon).

For salivary gland IF, third instar larvae were collected prior to the wandering stage. Salivary glands were dissected in EBR, pulsed with 50 μM EdU for 30 min and fixed with 4% formaldehyde. Salivary glands were incubated in anti-HP1 antibody (Developmental Studies Hybridoma Bank; C1A9) overnight at 4°C. Alexa Fluor secondary antibodies staining and Click-iT EdU labeling were performed as described above.

Image quantification {#s4-6}
--------------------

All images were quantified using Nikon NIS- Elements AR v4.40. To determine Rif1 and SUUR signal intensities at sites of gene amplification, Regions Of Interest (ROIs) were identified based on the EdU intensity. SUUR or Rif1 mean signal intensity was then determined within each ROI. Ten randomly selected regions outside of the nucleus were selected and the mean signal intensity for these regions were averaged to determine the background signal for each image. The average background signal was subtracted from the signal at amplified regions to normalize each image for varying amounts of background. To quantify the SUUR signal intensity at heterochromatin, SUUR ROIs were manually defined due to the their non-uniform shape. The sum intensity of the fluorescent signal within these regions were extracted. The sum signal intensity was then normalized to ROI area to account for the difference in shape of each ROI. To quantify PLA signals, ROIs were generated based on DAPI signal to mark all nuclei. PLA foci were then identified for each image and the number of foci in each DAPI ROI was determined.

Rif1 antibody production {#s4-7}
------------------------

Rif1 antiserum was produced in guinea pigs and rabbits (Cocalico Biologicals Inc.). Briefly, a Rif1 protein fragment from residues 694 -- 1094 ([@bib76]) was C-terminally six-histidine tagged and and expressed in *E. coli* Rossetta DE3 cells and purified using Ni-NTA Agarose beads (Qiagen). The purified protein was used for injection (Cocalico Biologicals Inc.) and serum was affinity purified as described ([@bib53]). Affinity purified guinea pig anti-Rif1 antibody was used for immunofluorescence.

IP-mass spec {#s4-8}
------------

Flies containing heat shock-inducible *SuUR* transgenes were expanded into population cages. 0 -- 24 hr embryos were collected, incubated at 37°C for 1 hr, and allowed to recover for one hour following heat shock treatment. Wild-type embryos were used as a negative control. Embryos were dechorionated in bleach and fixed for 20 min in 2% formaldehyde. Approximately 0.5 g of fixed and dechorionated embryos were used for each replicate. Embryos were disrupted by douncing in Buffer 1 ([@bib69]), followed by centrifugation at 3000 x g for 2 min at 4°C and resuspended in lysis buffer 3 ([@bib47]). Chromatin was prepared by sonicating nuclei for a total of 40 cycles of 30' ON and 30' OFF at max power using a Bioruptor 300 (Diagnenode) with vortexing and pausing after every 10 cycles. Cleared lysates were incubated with anti-FLAG M2 affinity gel (Sigma) for 2 hr at 4°C. After extensive washing in LB3 and LB3 with 1M NaCl, proteins were eluted using 3X FLAG peptide (Sigma). Crosslinks were reversed by boiling purified material in Laemmli buffer with β-mercaptoethanol for 20 min.

Immunoprecipitated samples were separated on a 4 -- 12% NuPAGE Bis-Tris gel (Invitrogen), proteins were stained with Novex colloidal Coomassie stain (Invitrogen), and destained in water. Coomassie stained gel regions were cut from the gel and diced into 1 mm^3^ cubes. Proteins were reduced and alkylated, destained with 50% MeCN in 25 mM ammonium bicarbonate, and in-gel digested with trypsin (10 ng/uL) in 25 mM ammonium bicarbonate overnight at 37°C. Peptides were extracted by gel dehydration with 60% MeCN, 0.1% TFA, the extracts were dried by speed vac centrifugation, and reconstituted in 0.1% formic acid. Peptides were analyzed by LC-coupled tandem mass spectrometry (LC-MS/MS). An analytical column was packed with 20 cm of C18 reverse phase material (Jupiter, 3 μm beads, 300 Å, Phenomenox) directly into a laser-pulled emitter tip. Peptides were loaded on the capillary reverse phase analytical column (360 μm O.D. x 100 μm I.D.) using a Dionex Ultimate 3000 nanoLC and autosampler. The mobile phase solvents consisted of 0.1% formic acid, 99.9% water (solvent A) and 0.1% formic acid, 99.9% acetonitrile (solvent B). Peptides were gradient-eluted at a flow rate of 350 nL/min, using a 120 min gradient. The gradient consisted of the following: 1 -- 3 min, 2% B (sample loading from autosampler); 3 -- 98 min, 2 -- 45% B; 98 -- 105 min, 45 -- 90% B; 105 -- 107 min, 90% B; 107 -- 110 min, 90--2% B; 110 -- 120 min (column re-equilibration), 2% B. A Q Exactive HF mass spectrometer (Thermo Scientific), equipped with a nanoelectrospray ionization source, was used to mass analyze the eluting peptides using a data-dependent method. The instrument method consisted of MS1 using an MS AGC target value of 3e6, followed by up to 15 MS/MS scans of the most abundant ions detected in the preceding MS scan. A maximum MS/MS ion time of 40 ms was used with a MS2 AGC target of 1e5. Dynamic exclusion was set to 20 s, HCD collision energy was set to 27 nce, and peptide match and isotope exclusion were enabled. For identification of peptides, tandem mass spectra were searched with Sequest (Thermo Fisher Scientific) against a *Drosophila melanogaster* database created from the UniprotKB protein database ([www.uniprot.org](http://www.uniprot.org)). Search results were assembled using Scaffold 4.3.4 (Proteome Software).

Genome-wide copy number profiling {#s4-9}
---------------------------------

Embryos were collected immediately after 2 hr of egg laying. Salivary glands were dissected in EBR from 50 wandering 3rd instar larvae per genotype and flash frozen. Ovaries were dissected from females fattened for 2 days on wet yeast in EBR and 50 stage 13 egg chambers were isolated for each genotype and flash frozen. Tissues were thawed on ice, resuspended in LB3 and dounced using a Kontes B-type pestle. Dounced homogenates were sonicated using a Bioruptor 300 (Diagenode) for 10 cycles of 30' on and 30'' off at maximal power. Lysates were treated with RNase and Proteinase K and genomic DNA was isolated by phenol-chloroform extraction. Illumina libraries were prepared using NEB DNA Ultra II (New England Biolabs) following the manufacturers protocol. Barcoded libraries were sequenced using Illumina NextSeq500 platform.

Bioinformatics {#s4-10}
--------------

Reads were mapped to the Drosophila genome (BDGP Release 6) using BWA-MEM with default parameters ([@bib45]). CNVnator 0.3.3 was used for the detection of underreplicated regions using a bin size of 1000 ([@bib1]). Regions were identified as underreplicated if they were not identified as underreplicated in 0 -- 2 hr embryonic DNA and were greater than 10 kb in length. The number of reads for underreplicated regions was called by using bedtools multicov tool for the underreplicated and uncalled regions. Average read depth per region was determined by multiplying the number of reads in a region by the read length and dividing by the total region length. Read depth was normalized between samples by scaling the total reads obtained per sample. Statistical comparison between the regions was with a t-test. For read depth in pericentric heterochromatin regions, the chromatin arm was binned into 10 kb windows and the number of reads for each window was called using bedtools multicov using only uniquely mapped reads.

Half maximum analysis of amplicon copy number profiles was performed as described previously ([@bib4]; [@bib56]). Briefly, log~2~ ratios were generated using bamCompare from deepTools 2.5.0 (Ramírez et al., n.d.) by comparing stage 13 follicle cell profiles to a 0 -- 2 hr embryo sample. Smoothed log~2~-transformed data was used to determine the point of maximum copy number associated with each amplicon. The chromosome coordinate corresponding to half the maximum value for each arm of the amplicon was then determined.

Copy number analysis by droplet-digital PCR (ddPCR) {#s4-11}
---------------------------------------------------

Genomic DNA was extracted from salivary glands isolated from wandering third instar larvae as described above. Primer sets annealing to the mid-point of the indicated UR regions were used (previously described in \[[@bib56]; [@bib71]\]). ddPCR was performed according to manufacture's recommendations (BioRad). All ddPCR reactions were performed in triplicate from three independent biological replicates. The concentration value for each set of primers in an underreplicated domain was divided by the concentration value of a fully replicated control to generate the bar graph. Error bars represent the SEM.

Western blotting {#s4-12}
----------------

Ovaries were dissected from females fattened for 2 days on wet yeast and suspended in Laemmli buffer supplemented with DTT. Ovaries were homogenized and boiled and extracts were loaded on a 4--20% Mini-PROTEAN TGX Stain-Free gel (BioRad). After electrophoresis the gel was activated and imaged according to the manufacturers recommendations. Protein was transferred to a PDVF membrane using a Trans-Blot Turbo Transfer System (BioRad). After blocking and incubation with antibodies, blots were imaged using an Amersham 600 CCD imager.

iPOND mass spectrometry {#s4-13}
-----------------------

We obtained *D. melanogaster* S2 cells directly from the Drosophila Genomics Resource Center (DGRC). Cells were checked for mycoplasma contamination by PCR. S2 cells propagated as recommended by the DGRC. *Drosophila* S2 cells were grown in Schneider's Drosophila Medium with 10% heat-inactivated FBS (Gemini Bio Products) and 100 units/mL Penicillin-Streptomycin (Life Technologies). For each biological replicate, 5 × 10^8^ cells were pulsed with 10 μM EdU and immediately fixed in 2% formaldehyde (pulse samples) or pulsed with 10 μM EdU for 10 minutes and chased with 100 μM Thymidine for 30 min prior to fixation (chase samples). iPOND purifications were done according to ([@bib24]) with the exception that LB3 was used in place of RIPA buffer. Purifications were processed for mass spectrometry as described above.

To quantify protein abundance in by mass spectrometry, raw mass spectrometry data were imported into Skyline version 4.1 ([@bib67]). Chromatographic traces were manually inspected for proper peak picking and where necessary adjusted manually in the chromatographic window. Only matching isotopic envelopes that had an error \<5 ppm, an isotope dot product \>0.9, and similar retention times between samples were used. MS1 peak areas from each peptide and observed charge state were summed to get the intensity for a given protein. To account for variation between samples, each sample was normalized to histone H3 summed areas.

Proximity Ligation Assay (PLA) with nascent DNA {#s4-14}
-----------------------------------------------

S2 cells were grown in Schneider's Drosophila Medium with 10% heat-inactivated FBS (Gemini Bio Products) and 100 units/mL Penicillin Streptomycin (Life Technologies). For nascent DNA PLA, asynchronously growing S2 cells were seeded onto Concanavalin A-coated coverslips. After attaching to coverslips for 1 hr, cells were pulsed with 125 µM EdU for 10 min. Cells were washed with PBS and fixed in 4% paraformaldehyde for 15 min, then permeabilized in PBS + 0.25% Triton X-100 for 60 min. The cells were biotinylated using standard click chemistry conditions for 30 min. After washing 3 times, blocking was performed for 1 hr with Duolink blocking solution. Cells were incubated with their primary antibody overnight at 4°C. The following day, cells were washed in Duolink Wash Buffer A, then incubated at 37°C with the appropriate Plus and Minus PLA probes at a 1:5 dilution. After an hour, the cells were washed in Wash Buffer A twice, ligation buffer was made at 1:40 dilution and incubated for 30 min at 37°C. Cells were washed 2x in Wash Buffer A, then incubated in amplification buffer at 1:80 for 100 min at 37°C. Slides were washed in Wash Buffer B, then 1:100 dilution of Wash Buffer B before being mounted in Duolink In Situ Mounting Media with DAPI.

Data access {#s4-15}
-----------

Data sets described in this manuscript can be found under the GEO accession number: GSE114370.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Rif1 inhibits replication fork progression and controls DNA copy number in *Drosophila*\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Jessica Tyler as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. Both reviewers found the work of general interest but each felt that certain biochemical experiments needed to be done to shore up the conclusions drawn from the genetics.

This manuscript reports the interesting finding that SuUR and Rif1 have a relationship to regulate DNA replication in different cell types of *Drosophila*. The manuscript is well written, the experiments well controlled, and the data well documented. It also reports new transgenes/mutants for both SuUR and Rif1. The data is convincing that SuUR and Rif1 co-purify, with certain caveats as to if the interactions are as direct as stated from embryos, and that both proteins promote under-replication in salivary glands and restrict the developmental window for fork progression during amplification. It is also convincing that Rif1 co-localizes to amplicon forks by immunnofluorescent labeling, that SuUR localization to these forks does not depend on Rif1, and that mutation of a putative PP1 interacting domain in Rif1 also results in more heterochromatic replication. The authors propose that the C terminal two-thirds of SUUR is important for interacting with an effector protein that suppresses replication fork progression. Thus they identify the protein as Rif1 and demonstrate that loss of Rif1 produces a phenotype similar to loss of SUUR: reversal of under-replication in endocyling cells. They show that Rif1 associates with elongating replication forks, that the association is dependent on SUUR and that the PP1 interacting motif of Rif1 is important for the suppression of replication fork progression.

As stated above, what is less clear is whether the SuUR and Rif1 interaction is direct, whether Rif1 inhibition of amplicon forks is \"direct\", and the extent to which fork progression versus origin activity explain the effect of Rif1 mutants on under-replication in polyploid salivary gland. These rather opposing ideas should be discussed. Indeed, the data presented suggest that Rif1 localization to forks and its effect on replication is only partially dependent on SuUR. In general, there is a deficit of biochemical approaches (e.g. iPOND, DNA fiber analysis, pull down) to bolster the conclusions from the genetic and cytological data. A previous report for a Rif1 effect on forks in frog extracts also partially compromises novelty. Therefore, although the manuscript reports some interesting findings, there are a number of changes that would address rigor. Major points for revision are put into context below and will be required for revisions.

Essential revisions:

1\) The authors conclude that Rif1 affects \"fork progression.\" This is based on two observations: a) Rif1 mutant salivary glands still have a late replication pattern of EdU incorporation but increased copy number of some heterochromatic DNA, b) IF co-localization of Rif1 with forks and an extended developmental time window of replication fork migration at amplicons in Rif1 mutants. The first argument in salivary glands is very indirect. Only a subset of the under-replicated loci in salivary glands are affected, others remain fully under-replicated, and it is not surprising that some of the late replication program would be retained. Moreover, it is not directly addressed to what extent Rif1\'s known activity at origins explains the increased DNA copy number in the mutant, e.g. activation of dormant origins. The second observation for amplification shows that the developmental time window is extended but does not address whether fork rate is affected. It seems like the manuscript stops short of doing the key experiments to show Rif1 directly affects fork rate/stability, i.e. iPOND and DNA fiber analysis during amplification and genomic replication. One or another of such experimental approaches needs to be done.

2\) The authors conclude that SNF2 domain is essential for SUUR function and replication fork localization. a) The authors should state in the Results that they are over-expressing the mutant using the hsp70 promoter. b) Does deletion of the SNF2 domain affect SUUR protein abundance (despite over-expression)? In Figure 1E, It appears some localization to heterochromatin remains but looks reduced. Is it possible to do a Western or other quantification of protein abundance? Going beyond those controls, has it been addressed whether the FLAG-SNF2 is sufficient for fork localization?

3\) The SUUR^ΔSNF^ localizes to heterochromatin but not the amplifying loci. Is the protein as stable and expressed at the same level as wild type SUUR?

4\) The SNF2 domain of SUUR did not co-IP Rif1. This is an important negative control. However, the co-IP was done after formaldehyde cross-linking like in a ChIP experiment. Are the authors sure that the SNF2 domain of SUUR is expressed to the same level as full length SUUR and localizes properly to the chromatin? In the same vein, is it possible that the interaction between SUUR and Rif1 will be lost if the samples were DNAsed? If the latter, then the idea that SUUR directly recruits Rif1 may be incorrect. SUUR may set up conditions at the fork that enable Rif1 to be recruited.

5\) A notable omission is that the authors do not mention whether Rif1 mutants have a DNA replication phenotype in diploid cells. Perhaps a comment on this even if not known would be worth mentioning

6\) The Rif1-PP1 mutant is believed to not interact with PP1 based on evolutionary arguments. A simple demonstration that WT Rif1 co-IPs PP1 (the authors have a very nice antibody to Rif1) and that the Rif1-PP1 mutant does not do so will greatly strengthen the hypothesis. Even with that result, it is still possible that the effector downstream of Rif1 is another protein (not PP1) that interacts with Rif1 near the same site as PP1. It is best to leave that possibility open.

10.7554/eLife.39140.041

Author response

> Essential revisions:
>
> 1\) The authors conclude that Rif1 affects \"fork progression.\" This is based on two observations: a) Rif1 mutant salivary glands still have a late replication pattern of EdU incorporation but increased copy number of some heterochromatic DNA, b) IF co-localization of Rif1 with forks and an extended developmental time window of replication fork migration at amplicons in Rif1 mutants. The first argument in salivary glands is very indirect. Only a subset of the under-replicated loci in salivary glands are affected, others remain fully under-replicated, and it is not surprising that some of the late replication program would be retained. Moreover, it is not directly addressed to what extent Rif1\'s known activity at origins explains the increased DNA copy number in the mutant, e.g. activation of dormant origins. The second observation for amplification shows that the developmental time window is extended but does not address whether fork rate is affected. It seems like the manuscript stops short of doing the key experiments to show Rif1 directly affects fork rate/stability, i.e. iPOND and DNA fiber analysis during amplification and genomic replication. One or another of such experimental approaches needs to be done.

Our conclusion that Rif1 affects replication fork progression is solely based on the observation that *Rif1* mutants exhibit increased replication fork progression in amplifying follicle cells without altering initiation of DNA replication. The observation that loss of Rif1 function suppresses under-replication merely raised the possibility that Rif1 could control replication fork progression in endo cycling cells based on what is known about SUUR function.

We would like to make clear that loss of Rif1 function results in increased fork progression at all amplicons without altering the developmental time window of gene amplification. We have measured the distribution of egg chambers in wild-type and Rif1 mutant follicle cells to make this clearer. If the developmental window for gene amplification was increased, we would expect to see an increase in amplification stage egg chambers in the Rif1 mutant. In contrast, we see no difference in egg chamber between wild-type and the Rif1 mutant. These data have been added as a Figure 4---figure supplement 1. The increased percentage of EdU+ stage 13 follicle cells we observe in the Rif1 mutant reflects that forks are more stable and therefore extend the window of EdU incorporation. Importantly, this prolonged EdU incorporation is occurring within the same 7.5 hour time window of gene amplification as in wild-type follicle cells. We have also changed the text to distinguish between the period of EdU incorporation and the developmental window of gene amplification to make this crucial point more clear.

We agree with the reviewers that DNA fiber analysis would be a convenient way to compare directly fork rates in under-replicated regions of wild-type and Rif1 mutant endo cycling cells. Under-replicated domains are where we predict Rif1 will have the strongest effect. Unfortunately, we would not be able to interpret this experiments because 1) UR domains are largely blocked for replication in wild-type endo cycling cells and 2) while UR is not complete, it is not known if the molecules that escape UR are at all affected by SUUR/Rif1. Therefore, we lack the proper, and interpretable, control for track length in UR domains for wild-type endo cycling cells. For example, the only visible tracks that we ultimately score within under-replicated domains may be those that are not affected by SUUR/Rif1.

We did, however, perform iPOND as the reviewers suggested. It is not feasible to perform iPOND in amplifying follicle cells due the large amount of hand-dissected material required for biochemical analysis. Therefore, we performed iPOND mass-spec in *Drosophila* cultured S2 cells and quantified Rif1 protein abundance in pulse and chase samples along with PCNA and Histone H1 controls, which should be enriched in the pulse and chase samples respectively. Our results reveal that Rif1 is enriched at replication forks in S2 cells and has been included as Figure 6---figure supplement 2A. Additionally, we used a proximity ligation assay (PLA)-based technique to monitor Rif1 localization at newly synthesized DNA. This recently developed technique, is the cytological equivalent of iPOND where the proximity of a protein of interest is monitored relative to newly synthesized DNA. Here show that Rif1 is associated with newly replicated DNA is cultured cells (Figure 6---figure supplement 2B).

> 2\) The authors conclude that SNF2 domain is essential for SUUR function and replication fork localization. a) The authors should state in the Results that they are over-expressing the mutant using the hsp70 promoter. b) Does deletion of the SNF2 domain affect SUUR protein abundance (despite over-expression)? In Figure 1E, It appears some localization to heterochromatin remains but looks reduced. Is it possible to do a Western or other quantification of protein abundance? Going beyond those controls, has it been addressed whether the FLAG-SNF2 is sufficient for fork localization?

Our observation that the SNF2 domain is essential for SUUR function was based on our analysis of the *SUUR^ΔSNF^* mutant, where we deleted the SNF2 domain of SUUR and expressed this mutant form of *SuUR* under control of its own promoter. This was described in the first paragraph of the Results subsection "The SNF2 domain is essential for SUUR function and replication fork localization". We did, however, use the *hsp70* promoter to overexpress the SNF2 domain and full length SUUR protein for IP-mass spec experiments where we identified an interaction between SUUR and Rif1. We have added the following sentence to make this clear in the Results section "We generated flies that expressed FLAG-tagged full length SUUR or the SNF2 domain of SUUR under control of the hsp70 promoter, immunoprecipitated these constructs and identified associated proteins through mass spectrometry." We also added included the following statement in the Materials and methods section "The resulting construct was cloned into the pCaSpeR-hs vector, which contains a *hsp70* promoter (Thummel and Pirrotta, V.: *Drosophila* Genomics Resource Center"

Unfortunately, no reagents exist to monitor endogenous SUUR by Western blotting, which limits our ability to ensure that the SUUR^ΔSNF^ mutant is maintained at the same levels as wild-type SUUR. What we were able to do, however, is quantify the signal intensity of SUUR and SUUR^ΔSNF^ proteins at heterochromatin by quantitative IF. This analysis revealed no significant difference in levels of SUUR and SUUR^ΔSNF^ protein signal at heterochromatin, while there is a dramatic difference in SUUR and SUUR^ΔSNF^ protein levels at sites of amplification. This data has now been added as Figure 1---figure supplement 2.

We currently do not know if FLAG-SNF2 is sufficient for fork localization. When we monitor FLAG-SNF2 localization in follicle cells, we see a strong staining throughout the nucleus. It is possible that this construct is at replication forks, but the overall chromatin signal may be masking signal at amplification regions.

> 3\) The SUUR^ΔSNF^ localizes to heterochromatin but not the amplifying loci. Is the protein as stable and expressed at the same level as wild type SUUR?

See above. There are no available reagents to monitor endogenous SUUR protein by Western blotting. We have performed quantitative IF and shown that there is no difference in the protein signal of SUUR and SUUR^ΔSNF^ at heterochromatin.

> 4\) The SNF2 domain of SUUR did not co-IP Rif1. This is an important negative control. However, the co-IP was done after formaldehyde cross-linking like in a ChIP experiment. Are the authors sure that the SNF2 domain of SUUR is expressed to the same level as full length SUUR and localizes properly to the chromatin? In the same vein, is it possible that the interaction between SUUR and Rif1 will be lost if the samples were DNAsed? If the latter, then the idea that SUUR directly recruits Rif1 may be incorrect. SUUR may set up conditions at the fork that enable Rif1 to be recruited.

We agree with the reviewers that we have not provided any evidence that the interaction between Rif1 and SUUR is direct. We initially described the interaction as a 'physical interaction' to distinguish it from a genetic interaction. We have now repeated the IP in the absence of crosslinking, +/- benzonase, to support the idea that SUUR recruits Rif1 to replication forks rather than setting up a condition at the fork that enables Rif1 to be recruited. Our new results show a robust interaction between SUUR and Rif1 using NP40 extraction and treating extracts with benzonase to cleave DNA. We've combined these data with our initial Table 1 as a single figure (Figure 2). We have not been able to purify full-length SUUR for in vitro binding assays to test directness, however, our new results provide much more compelling evidence that SUUR and Rif1 are closely associated. We have described SUUR and Rif1 as being in the same complex rather than a physical interaction to avoid confusion.

> 5\) A notable omission is that the authors do not mention whether Rif1 mutants have a DNA replication phenotype in diploid cells. Perhaps a comment on this even if not known would be worth mentioning

While preparing this manuscript, Seller and O'Farrell published an elegant paper on the role of Rif1 in the diploid cells of the early embryo (Seller and O'Farrell, 2018). They demonstrate that Rif1 localizes to heterochromatin and is necessary to establish a program of late replication at the MBT. We have cited this manuscript and commented when appropriate.

> 6\) The Rif1-PP1 mutant is believed to not interact with PP1 based on evolutionary arguments. A simple demonstration that WT Rif1 co-IPs PP1 (the authors have a very nice antibody to Rif1) and that the Rif1-PP1 mutant does not do so will greatly strengthen the hypothesis. Even with that result, it is still possible that the effector downstream of Rif1 is another protein (not PP1) that interacts with Rif1 near the same site as PP1. It is best to leave that possibility open.

In the Seller and O'Farrell manuscript referenced above, it was shown that Rif1 can co-IP PP1. Furthermore, Sreesankar et al., previously demonstrated that an HA tagged version of PP1 could co-IP Rif1 (Sreesankar et al., 2015). We have tried to co-IP PP1 with Rif1 using our antibody and have found, unfortunately, that our antibody blocks that interaction between Rif1 and PP1. The epitope we used to generate the antibodies included the PP1-binding motif. Regardless, we agree with the reviewers that we cannot exclude the possibility that another downstream effector molecule other then PP1 interacts with this region. We have raised this possibility in the Results and Discussion sections and have been careful to say that the PP1-binding motif is essential for Rif1 function rather than PP1 binding or an interaction between Rif1 and PP1.
